Differences in pre- and post-synaptic sensitivity to apomorphine between saline and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57BL/6 mice as reflected in climbing activity

European Journal of Pharmacology

Volumn 353, Issue 1, 1998, Pages 1-4

  Spooren, Will P J M ^a   Vassout, Annick ^a   Waldmeier, Peter ^a   Gentsch, Conrad ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Apomorphine; C57BL 6; Climbing; Dopamine; Mouse; MPTP (1 methyl 4 phenyl 1,2,3,6 tetrahydropyridine)

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3,4 DIHYDROXYPHENYLACETIC ACID; APOMORPHINE; DOPAMINE; HOMOVANILLIC ACID; POSTSYNAPTIC RECEPTOR; PRESYNAPTIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CLIMBING; CONTROLLED STUDY; DRUG EFFECT; HABITUATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; APOMORPHINE; CORPUS STRIATUM; DOPAMINE AGENTS; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HABITUATION, PSYCHOPHYSIOLOGIC; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; MPTP POISONING; RECEPTORS, PRESYNAPTIC; SODIUM CHLORIDE; SYNAPSES;

EID: 0031877794     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00382-3     Document Type: Article

References (15)

1. Burns, R.A., Chieuh, C.C., Markey, S.P., Elbert, M.H., Jacobowitz, D.M., Kopin, I.J., 1983. A primate model of Parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA 80, 4546-4550.
2. Davis, C.G., Williams, A.C., Markey, S.P., Elbert, M.H., Calne, E.D., Reichert, C.M., Kopin, I.J., 1978. Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res. 1, 249-254.
3. Fredriksson, A., Plaznik, A., Sundström, E., Jonsson, G., Archer, T., 1990. MPTP-induced hypoactivity in mice: reversal by L-dopa. Pharmacol. Toxicol. 67, 295-301.
4. Gendreau, P.L., Petitto, J.M., Schnauss, R., Frantz, K.J., Van Hartesveldt, C., Gariepy, J.L., Lewis, M.H., 1997. Effects of the putative dopamine D3 receptor agonist PNU 99194A on motor behaviour and emotional reactivity in C57BL/6J mice. European Journal of Pharmacology 337, 147-155.
5. Heikkila, R.E., Hess, A., Duvoisin, R.C., 1984. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Science 224, 1435-1451.
6. Langston, J.W., Ballard, P., Tetrud, J.W., Irwin, I., 1983. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979-980.
7. Lau, Y.-S., Fung, Y.K., 1986. Pharmacological effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine receptor system. Brain Res. 369, 311-315.
8. Protais, P., Constentin, J., Schwartz, J.C., 1976. Climbing behaviour induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatum. Psychopharmacology 50, 1-6.
9. Starr, M.S., Starr, B.S., 1995. Motor actions of 7-OH-DPAT in normal and reserpine-treated mice suggest involvement of both dopamine D2 and D3 receptors. European Journal of Pharmacology 277, 151-158.
10. Sundström, E., Fredrikson, A., Archer, T., 1990. Chronic neurochemical and behavioural changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's disease. Brain Res. 528, 181-188.
11. Sundström, E., Henriksson, B.G., Mohammed, A.H., Souverbie, F., 1994. MPTP-treated mice: a useful model for Parkinson's disease? In: Woodruff, L., Nonneman, A.J., (Eds.), Toxin-Induced Models of Neurological Disorders. Plenum, New York, NY, pp. 121-137.
12. Vasse, M., Protais, P., 1989. Potentiation of apomorphine-induced stereotyped behaviour by acute treatment with dopamine depleting agents: a potential role for an increased stimulation of D1 dopamine receptors. Neuropharmacolgy 28, 931-939.
13. Weihmuller, F.B., Bruno, J.P., Neff, N.H., Hadjiconstantinou, M., 1990. Dopamine receptor plasticity following MPTP-induced nigrostriatal lesions in the mouse. European Journal of Pharmacology 16, 369-372.
14. Wiener, H.L., Lajtha, A., Sershen, H., 1989. Dopamine D1 receptor and dopamine D2 receptor binding activity changes during chronic administration of nicotine in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice. Neuropharmacology 28, 535-537.
15. Willis, G.L., Donnan, G.A., 1987. Histochemical biochemical and behavioural consequences of MPTP treatment in C-57 black mice. Brain Res. 402, 269-274.